Ophthalmology — glaucoma, anti-infective, anti-inflammatory, intravitreal · ATC S01LA. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
No per‑unit prices are published for this molecule in India or the UAE at a matching strength yet. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
Ophthalmology — glaucoma, anti-infective, anti-inflammatory, intravitreal · Ophthalmology · ATC S01LA.
Procurement note: Biosimilar ranibizumab/aflibercept — large saving; bevacizumab compounding policy; pre-filled syringes.
Usual forms: 0.5 mg; 2 mg, 8 mg; 1.25 mg (compounded); 6 mg; 6 mg.
Brands · India: Razumab (biosimilar ranibizumab), Lucentis; Eylea, Aflibercept biosimilars (2024+); Avastin (compounded); Vabysmo
Brands · UAE/GCC seen in tenders: Lucentis, Byooviz (biosimilar); Eylea, Yesafili (biosimilar); Vabysmo; Beovu
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.